Letters to the editor [2]

dc.contributor.authorBoffard K.D.
dc.contributor.authorChoong P.I.T.
dc.contributor.authorKluger Y.
dc.contributor.authorRiou B.
dc.contributor.authorRizoli S.
dc.contributor.authorRossaint R.
dc.contributor.authorWarren B.
dc.date.accessioned2011-05-15T16:17:11Z
dc.date.available2011-05-15T16:17:11Z
dc.date.issued2006
dc.description.abstract[No abstract available]
dc.description.versionLetter
dc.identifier.citationJournal of Trauma - Injury, Infection and Critical Care
dc.identifier.citation60
dc.identifier.citation1
dc.identifier.issn00225282
dc.identifier.other10.1097/01.ta.0000197375.34928.87
dc.identifier.urihttp://hdl.handle.net/10019.1/14108
dc.subjectplacebo
dc.subjectrecombinant blood clotting factor 7a
dc.subjectbleeding
dc.subjectblood transfusion
dc.subjectblunt trauma
dc.subjectcause of death
dc.subjectclinical trial
dc.subjectcontrolled clinical trial
dc.subjectcontrolled study
dc.subjectdrug efficacy
dc.subjectdrug industry
dc.subjectdrug marketing
dc.subjectdrug safety
dc.subjecthealth care quality
dc.subjecthuman
dc.subjectinjury severity
dc.subjectletter
dc.subjectoutcome assessment
dc.subjectpenetrating trauma
dc.subjectphase 2 clinical trial
dc.subjectpriority journal
dc.subjectrandomized controlled trial
dc.subjecttreatment indication
dc.titleLetters to the editor [2]
dc.typeLetter
Files